- Have mild, moderate or severe plaque psoriasis (psoriasis vulgaris) for at least 6
months prior to Baseline
- At Baseline, have plaque psoriasis covering 2% to 20% of total body surface area (BSA)
on the trunk and limbs (excluding palms, soles, and nails)
- If received certain treatments, should be off treatment for a minimum period of time
(washout)
- Currently have non-plaque forms of psoriasis or drug-induced psoriasis
- Require treatment with or cannot stop medication(s) prohibited during the study
- Have certain laboratory abnormalities at Baseline
- Current or history of certain infections
- Females who are pregnant, breastfeeding, or are of childbearing potential not using
highly effective contraception